nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—CYP3A5—Gefitinib—lung cancer	0.0629	0.087	CbGbCtD
Halofantrine—CYP3A5—Teniposide—lung cancer	0.061	0.0844	CbGbCtD
Halofantrine—CYP2D6—Gefitinib—lung cancer	0.0386	0.0534	CbGbCtD
Halofantrine—CYP3A5—Crizotinib—lung cancer	0.0386	0.0534	CbGbCtD
Halofantrine—CYP3A5—Erlotinib—lung cancer	0.0372	0.0515	CbGbCtD
Halofantrine—CYP2C8—Erlotinib—lung cancer	0.0358	0.0495	CbGbCtD
Halofantrine—CYP3A5—Paclitaxel—lung cancer	0.034	0.0471	CbGbCtD
Halofantrine—CYP3A5—Irinotecan—lung cancer	0.0336	0.0465	CbGbCtD
Halofantrine—CYP2C8—Paclitaxel—lung cancer	0.0327	0.0453	CbGbCtD
Halofantrine—CYP2D6—Vinorelbine—lung cancer	0.0297	0.0411	CbGbCtD
Halofantrine—CYP3A5—Etoposide—lung cancer	0.0269	0.0372	CbGbCtD
Halofantrine—CYP3A4—Topotecan—lung cancer	0.0268	0.0371	CbGbCtD
Halofantrine—CYP2C8—Etoposide—lung cancer	0.0259	0.0358	CbGbCtD
Halofantrine—CYP3A5—Docetaxel—lung cancer	0.0246	0.0341	CbGbCtD
Halofantrine—CYP3A4—Gefitinib—lung cancer	0.0245	0.0339	CbGbCtD
Halofantrine—CYP3A4—Teniposide—lung cancer	0.0238	0.0329	CbGbCtD
Halofantrine—CYP2D6—Erlotinib—lung cancer	0.0228	0.0316	CbGbCtD
Halofantrine—CYP3A4—Vinorelbine—lung cancer	0.0189	0.0261	CbGbCtD
Halofantrine—CYP2D6—Vinblastine—lung cancer	0.0183	0.0253	CbGbCtD
Halofantrine—CYP3A4—Crizotinib—lung cancer	0.015	0.0208	CbGbCtD
Halofantrine—CYP3A4—Erlotinib—lung cancer	0.0145	0.0201	CbGbCtD
Halofantrine—CYP3A4—Paclitaxel—lung cancer	0.0133	0.0184	CbGbCtD
Halofantrine—CYP3A4—Irinotecan—lung cancer	0.0131	0.0181	CbGbCtD
Halofantrine—CYP3A4—Vinblastine—lung cancer	0.0116	0.0161	CbGbCtD
Halofantrine—CYP2D6—Doxorubicin—lung cancer	0.0113	0.0156	CbGbCtD
Halofantrine—CYP3A4—Etoposide—lung cancer	0.0105	0.0145	CbGbCtD
Halofantrine—CYP3A4—Docetaxel—lung cancer	0.0096	0.0133	CbGbCtD
Halofantrine—CYP3A4—Doxorubicin—lung cancer	0.00716	0.0099	CbGbCtD
Halofantrine—Malaise—Cisplatin—lung cancer	0.000342	0.00176	CcSEcCtD
Halofantrine—Pruritus—Topotecan—lung cancer	0.000342	0.00176	CcSEcCtD
Halofantrine—Anaphylactic shock—Irinotecan—lung cancer	0.000341	0.00175	CcSEcCtD
Halofantrine—Feeling abnormal—Vinorelbine—lung cancer	0.00034	0.00175	CcSEcCtD
Halofantrine—Diarrhoea—Vinblastine—lung cancer	0.00034	0.00175	CcSEcCtD
Halofantrine—Pruritus—Erlotinib—lung cancer	0.000338	0.00174	CcSEcCtD
Halofantrine—Gastrointestinal pain—Vinorelbine—lung cancer	0.000338	0.00174	CcSEcCtD
Halofantrine—Back pain—Etoposide—lung cancer	0.000336	0.00173	CcSEcCtD
Halofantrine—Anaphylactic shock—Gemcitabine—lung cancer	0.000332	0.00171	CcSEcCtD
Halofantrine—Diarrhoea—Topotecan—lung cancer	0.00033	0.0017	CcSEcCtD
Halofantrine—Back pain—Paclitaxel—lung cancer	0.000329	0.0017	CcSEcCtD
Halofantrine—Dizziness—Vinblastine—lung cancer	0.000329	0.00169	CcSEcCtD
Halofantrine—Convulsion—Cisplatin—lung cancer	0.000328	0.00169	CcSEcCtD
Halofantrine—Urticaria—Vinorelbine—lung cancer	0.000328	0.00169	CcSEcCtD
Halofantrine—Diarrhoea—Erlotinib—lung cancer	0.000327	0.00168	CcSEcCtD
Halofantrine—Abdominal pain—Vinorelbine—lung cancer	0.000327	0.00168	CcSEcCtD
Halofantrine—Anorexia—Irinotecan—lung cancer	0.000325	0.00167	CcSEcCtD
Halofantrine—Myalgia—Cisplatin—lung cancer	0.000323	0.00166	CcSEcCtD
Halofantrine—Ill-defined disorder—Etoposide—lung cancer	0.000322	0.00166	CcSEcCtD
Halofantrine—Visual impairment—Docetaxel—lung cancer	0.000319	0.00164	CcSEcCtD
Halofantrine—Dizziness—Topotecan—lung cancer	0.000319	0.00164	CcSEcCtD
Halofantrine—Discomfort—Cisplatin—lung cancer	0.000319	0.00164	CcSEcCtD
Halofantrine—Anorexia—Gemcitabine—lung cancer	0.000316	0.00163	CcSEcCtD
Halofantrine—Vomiting—Vinblastine—lung cancer	0.000316	0.00163	CcSEcCtD
Halofantrine—Dizziness—Erlotinib—lung cancer	0.000316	0.00163	CcSEcCtD
Halofantrine—Ill-defined disorder—Paclitaxel—lung cancer	0.000316	0.00163	CcSEcCtD
Halofantrine—Malaise—Etoposide—lung cancer	0.000313	0.00161	CcSEcCtD
Halofantrine—Headache—Vinblastine—lung cancer	0.000311	0.0016	CcSEcCtD
Halofantrine—Anaphylactic shock—Cisplatin—lung cancer	0.000309	0.00159	CcSEcCtD
Halofantrine—Vomiting—Topotecan—lung cancer	0.000307	0.00158	CcSEcCtD
Halofantrine—Malaise—Paclitaxel—lung cancer	0.000307	0.00158	CcSEcCtD
Halofantrine—Paraesthesia—Irinotecan—lung cancer	0.000306	0.00158	CcSEcCtD
Halofantrine—Cerebrovascular accident—Doxorubicin—lung cancer	0.000305	0.00157	CcSEcCtD
Halofantrine—Rash—Topotecan—lung cancer	0.000304	0.00157	CcSEcCtD
Halofantrine—Dermatitis—Topotecan—lung cancer	0.000304	0.00157	CcSEcCtD
Halofantrine—Vomiting—Erlotinib—lung cancer	0.000304	0.00156	CcSEcCtD
Halofantrine—Cough—Etoposide—lung cancer	0.000303	0.00156	CcSEcCtD
Halofantrine—Headache—Topotecan—lung cancer	0.000302	0.00156	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000302	0.00156	CcSEcCtD
Halofantrine—Rash—Erlotinib—lung cancer	0.000301	0.00155	CcSEcCtD
Halofantrine—Dermatitis—Erlotinib—lung cancer	0.000301	0.00155	CcSEcCtD
Halofantrine—Palpitations—Paclitaxel—lung cancer	0.000301	0.00155	CcSEcCtD
Halofantrine—Convulsion—Etoposide—lung cancer	0.000301	0.00155	CcSEcCtD
Halofantrine—Dyspepsia—Irinotecan—lung cancer	0.0003	0.00154	CcSEcCtD
Halofantrine—Headache—Erlotinib—lung cancer	0.000299	0.00154	CcSEcCtD
Halofantrine—Paraesthesia—Gemcitabine—lung cancer	0.000298	0.00153	CcSEcCtD
Halofantrine—Chills—Docetaxel—lung cancer	0.000297	0.00153	CcSEcCtD
Halofantrine—Cough—Paclitaxel—lung cancer	0.000297	0.00153	CcSEcCtD
Halofantrine—Asthenia—Vinorelbine—lung cancer	0.000296	0.00153	CcSEcCtD
Halofantrine—Decreased appetite—Irinotecan—lung cancer	0.000296	0.00152	CcSEcCtD
Halofantrine—Arrhythmia—Docetaxel—lung cancer	0.000296	0.00152	CcSEcCtD
Halofantrine—Chest pain—Etoposide—lung cancer	0.000296	0.00152	CcSEcCtD
Halofantrine—Nausea—Vinblastine—lung cancer	0.000295	0.00152	CcSEcCtD
Halofantrine—Convulsion—Paclitaxel—lung cancer	0.000295	0.00152	CcSEcCtD
Halofantrine—Anorexia—Cisplatin—lung cancer	0.000295	0.00152	CcSEcCtD
Halofantrine—Fatigue—Irinotecan—lung cancer	0.000294	0.00151	CcSEcCtD
Halofantrine—Pruritus—Vinorelbine—lung cancer	0.000292	0.0015	CcSEcCtD
Halofantrine—Discomfort—Etoposide—lung cancer	0.000292	0.0015	CcSEcCtD
Halofantrine—Constipation—Irinotecan—lung cancer	0.000291	0.0015	CcSEcCtD
Halofantrine—Chest pain—Paclitaxel—lung cancer	0.00029	0.00149	CcSEcCtD
Halofantrine—Arthralgia—Paclitaxel—lung cancer	0.00029	0.00149	CcSEcCtD
Halofantrine—Myalgia—Paclitaxel—lung cancer	0.00029	0.00149	CcSEcCtD
Halofantrine—Face oedema—Doxorubicin—lung cancer	0.000289	0.00149	CcSEcCtD
Halofantrine—Decreased appetite—Gemcitabine—lung cancer	0.000288	0.00149	CcSEcCtD
Halofantrine—Nausea—Topotecan—lung cancer	0.000287	0.00148	CcSEcCtD
Halofantrine—Discomfort—Paclitaxel—lung cancer	0.000286	0.00147	CcSEcCtD
Halofantrine—Fatigue—Gemcitabine—lung cancer	0.000286	0.00147	CcSEcCtD
Halofantrine—Confusional state—Etoposide—lung cancer	0.000286	0.00147	CcSEcCtD
Halofantrine—Constipation—Gemcitabine—lung cancer	0.000284	0.00146	CcSEcCtD
Halofantrine—Nausea—Erlotinib—lung cancer	0.000284	0.00146	CcSEcCtD
Halofantrine—Anaphylactic shock—Etoposide—lung cancer	0.000283	0.00146	CcSEcCtD
Halofantrine—Diarrhoea—Vinorelbine—lung cancer	0.000283	0.00146	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000282	0.00145	CcSEcCtD
Halofantrine—Feeling abnormal—Irinotecan—lung cancer	0.000281	0.00145	CcSEcCtD
Halofantrine—Confusional state—Paclitaxel—lung cancer	0.00028	0.00144	CcSEcCtD
Halofantrine—Back pain—Docetaxel—lung cancer	0.000279	0.00144	CcSEcCtD
Halofantrine—Gastrointestinal pain—Irinotecan—lung cancer	0.000279	0.00143	CcSEcCtD
Halofantrine—Anaphylactic shock—Paclitaxel—lung cancer	0.000278	0.00143	CcSEcCtD
Halofantrine—Paraesthesia—Cisplatin—lung cancer	0.000278	0.00143	CcSEcCtD
Halofantrine—Feeling abnormal—Gemcitabine—lung cancer	0.000273	0.00141	CcSEcCtD
Halofantrine—Dizziness—Vinorelbine—lung cancer	0.000273	0.00141	CcSEcCtD
Halofantrine—Orthostatic hypotension—Doxorubicin—lung cancer	0.000273	0.00141	CcSEcCtD
Halofantrine—Anorexia—Etoposide—lung cancer	0.00027	0.00139	CcSEcCtD
Halofantrine—Abdominal pain—Irinotecan—lung cancer	0.000269	0.00139	CcSEcCtD
Halofantrine—Decreased appetite—Cisplatin—lung cancer	0.000269	0.00138	CcSEcCtD
Halofantrine—Anorexia—Paclitaxel—lung cancer	0.000265	0.00136	CcSEcCtD
Halofantrine—Vomiting—Vinorelbine—lung cancer	0.000263	0.00135	CcSEcCtD
Halofantrine—Rash—Vinorelbine—lung cancer	0.00026	0.00134	CcSEcCtD
Halofantrine—Dermatitis—Vinorelbine—lung cancer	0.00026	0.00134	CcSEcCtD
Halofantrine—Abdominal distension—Doxorubicin—lung cancer	0.00026	0.00134	CcSEcCtD
Halofantrine—Stomatitis—Methotrexate—lung cancer	0.000259	0.00134	CcSEcCtD
Halofantrine—Headache—Vinorelbine—lung cancer	0.000259	0.00133	CcSEcCtD
Halofantrine—Palpitations—Docetaxel—lung cancer	0.000255	0.00131	CcSEcCtD
Halofantrine—Feeling abnormal—Cisplatin—lung cancer	0.000255	0.00131	CcSEcCtD
Halofantrine—Paraesthesia—Etoposide—lung cancer	0.000254	0.00131	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000253	0.0013	CcSEcCtD
Halofantrine—Cough—Docetaxel—lung cancer	0.000252	0.0013	CcSEcCtD
Halofantrine—Convulsion—Docetaxel—lung cancer	0.00025	0.00129	CcSEcCtD
Halofantrine—Paraesthesia—Paclitaxel—lung cancer	0.000249	0.00128	CcSEcCtD
Halofantrine—Decreased appetite—Etoposide—lung cancer	0.000246	0.00127	CcSEcCtD
Halofantrine—Arthralgia—Docetaxel—lung cancer	0.000246	0.00126	CcSEcCtD
Halofantrine—Myalgia—Docetaxel—lung cancer	0.000246	0.00126	CcSEcCtD
Halofantrine—Chest pain—Docetaxel—lung cancer	0.000246	0.00126	CcSEcCtD
Halofantrine—Nausea—Vinorelbine—lung cancer	0.000245	0.00126	CcSEcCtD
Halofantrine—Dyspepsia—Paclitaxel—lung cancer	0.000245	0.00126	CcSEcCtD
Halofantrine—Asthenia—Irinotecan—lung cancer	0.000244	0.00126	CcSEcCtD
Halofantrine—Fatigue—Etoposide—lung cancer	0.000244	0.00126	CcSEcCtD
Halofantrine—Constipation—Etoposide—lung cancer	0.000242	0.00125	CcSEcCtD
Halofantrine—Decreased appetite—Paclitaxel—lung cancer	0.000242	0.00124	CcSEcCtD
Halofantrine—Fatigue—Paclitaxel—lung cancer	0.00024	0.00123	CcSEcCtD
Halofantrine—Pollakiuria—Doxorubicin—lung cancer	0.000239	0.00123	CcSEcCtD
Halofantrine—Asthenia—Gemcitabine—lung cancer	0.000238	0.00123	CcSEcCtD
Halofantrine—Constipation—Paclitaxel—lung cancer	0.000238	0.00122	CcSEcCtD
Halofantrine—Confusional state—Docetaxel—lung cancer	0.000237	0.00122	CcSEcCtD
Halofantrine—Anaphylactic shock—Docetaxel—lung cancer	0.000235	0.00121	CcSEcCtD
Halofantrine—Pruritus—Gemcitabine—lung cancer	0.000235	0.00121	CcSEcCtD
Halofantrine—Feeling abnormal—Etoposide—lung cancer	0.000234	0.0012	CcSEcCtD
Halofantrine—Diarrhoea—Irinotecan—lung cancer	0.000233	0.0012	CcSEcCtD
Halofantrine—Gastrointestinal pain—Etoposide—lung cancer	0.000232	0.00119	CcSEcCtD
Halofantrine—Visual impairment—Methotrexate—lung cancer	0.00023	0.00119	CcSEcCtD
Halofantrine—Feeling abnormal—Paclitaxel—lung cancer	0.000229	0.00118	CcSEcCtD
Halofantrine—Gastrointestinal pain—Paclitaxel—lung cancer	0.000227	0.00117	CcSEcCtD
Halofantrine—Diarrhoea—Gemcitabine—lung cancer	0.000227	0.00117	CcSEcCtD
Halofantrine—Dizziness—Irinotecan—lung cancer	0.000225	0.00116	CcSEcCtD
Halofantrine—Urticaria—Etoposide—lung cancer	0.000225	0.00116	CcSEcCtD
Halofantrine—Stomatitis—Doxorubicin—lung cancer	0.000225	0.00116	CcSEcCtD
Halofantrine—Anorexia—Docetaxel—lung cancer	0.000224	0.00116	CcSEcCtD
Halofantrine—Abdominal pain—Etoposide—lung cancer	0.000224	0.00115	CcSEcCtD
Halofantrine—Tinnitus—Methotrexate—lung cancer	0.000223	0.00115	CcSEcCtD
Halofantrine—Asthenia—Cisplatin—lung cancer	0.000222	0.00114	CcSEcCtD
Halofantrine—Urticaria—Paclitaxel—lung cancer	0.000221	0.00114	CcSEcCtD
Halofantrine—Abdominal pain—Paclitaxel—lung cancer	0.00022	0.00113	CcSEcCtD
Halofantrine—Vomiting—Irinotecan—lung cancer	0.000217	0.00112	CcSEcCtD
Halofantrine—Rash—Irinotecan—lung cancer	0.000215	0.00111	CcSEcCtD
Halofantrine—Dermatitis—Irinotecan—lung cancer	0.000215	0.0011	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000215	0.0011	CcSEcCtD
Halofantrine—Chills—Methotrexate—lung cancer	0.000214	0.0011	CcSEcCtD
Halofantrine—Headache—Irinotecan—lung cancer	0.000213	0.0011	CcSEcCtD
Halofantrine—Diarrhoea—Cisplatin—lung cancer	0.000212	0.00109	CcSEcCtD
Halofantrine—Paraesthesia—Docetaxel—lung cancer	0.000211	0.00109	CcSEcCtD
Halofantrine—Vomiting—Gemcitabine—lung cancer	0.000211	0.00109	CcSEcCtD
Halofantrine—Rash—Gemcitabine—lung cancer	0.000209	0.00108	CcSEcCtD
Halofantrine—Dermatitis—Gemcitabine—lung cancer	0.000209	0.00108	CcSEcCtD
Halofantrine—Headache—Gemcitabine—lung cancer	0.000208	0.00107	CcSEcCtD
Halofantrine—Dyspepsia—Docetaxel—lung cancer	0.000207	0.00107	CcSEcCtD
Halofantrine—Decreased appetite—Docetaxel—lung cancer	0.000205	0.00105	CcSEcCtD
Halofantrine—Asthenia—Etoposide—lung cancer	0.000203	0.00105	CcSEcCtD
Halofantrine—Fatigue—Docetaxel—lung cancer	0.000203	0.00105	CcSEcCtD
Halofantrine—Nausea—Irinotecan—lung cancer	0.000202	0.00104	CcSEcCtD
Halofantrine—Constipation—Docetaxel—lung cancer	0.000201	0.00104	CcSEcCtD
Halofantrine—Back pain—Methotrexate—lung cancer	0.000201	0.00104	CcSEcCtD
Halofantrine—Pruritus—Etoposide—lung cancer	0.0002	0.00103	CcSEcCtD
Halofantrine—Visual impairment—Doxorubicin—lung cancer	0.000199	0.00103	CcSEcCtD
Halofantrine—Asthenia—Paclitaxel—lung cancer	0.000199	0.00103	CcSEcCtD
Halofantrine—Nausea—Gemcitabine—lung cancer	0.000197	0.00101	CcSEcCtD
Halofantrine—Vomiting—Cisplatin—lung cancer	0.000197	0.00101	CcSEcCtD
Halofantrine—Pruritus—Paclitaxel—lung cancer	0.000197	0.00101	CcSEcCtD
Halofantrine—Rash—Cisplatin—lung cancer	0.000195	0.001	CcSEcCtD
Halofantrine—Dermatitis—Cisplatin—lung cancer	0.000195	0.001	CcSEcCtD
Halofantrine—Feeling abnormal—Docetaxel—lung cancer	0.000194	0.000999	CcSEcCtD
Halofantrine—Diarrhoea—Etoposide—lung cancer	0.000194	0.000998	CcSEcCtD
Halofantrine—Ill-defined disorder—Methotrexate—lung cancer	0.000193	0.000994	CcSEcCtD
Halofantrine—Tinnitus—Doxorubicin—lung cancer	0.000193	0.000993	CcSEcCtD
Halofantrine—Gastrointestinal pain—Docetaxel—lung cancer	0.000193	0.000992	CcSEcCtD
Halofantrine—Diarrhoea—Paclitaxel—lung cancer	0.00019	0.000979	CcSEcCtD
Halofantrine—Malaise—Methotrexate—lung cancer	0.000188	0.000966	CcSEcCtD
Halofantrine—Dizziness—Etoposide—lung cancer	0.000187	0.000965	CcSEcCtD
Halofantrine—Abdominal pain—Docetaxel—lung cancer	0.000186	0.000959	CcSEcCtD
Halofantrine—Chills—Doxorubicin—lung cancer	0.000186	0.000956	CcSEcCtD
Halofantrine—Arrhythmia—Doxorubicin—lung cancer	0.000185	0.000952	CcSEcCtD
Halofantrine—Dizziness—Paclitaxel—lung cancer	0.000184	0.000946	CcSEcCtD
Halofantrine—Nausea—Cisplatin—lung cancer	0.000184	0.000946	CcSEcCtD
Halofantrine—Cough—Methotrexate—lung cancer	0.000181	0.000934	CcSEcCtD
Halofantrine—Convulsion—Methotrexate—lung cancer	0.00018	0.000928	CcSEcCtD
Halofantrine—Vomiting—Etoposide—lung cancer	0.00018	0.000928	CcSEcCtD
Halofantrine—Rash—Etoposide—lung cancer	0.000179	0.00092	CcSEcCtD
Halofantrine—Dermatitis—Etoposide—lung cancer	0.000179	0.000919	CcSEcCtD
Halofantrine—Headache—Etoposide—lung cancer	0.000178	0.000914	CcSEcCtD
Halofantrine—Arthralgia—Methotrexate—lung cancer	0.000177	0.000912	CcSEcCtD
Halofantrine—Chest pain—Methotrexate—lung cancer	0.000177	0.000912	CcSEcCtD
Halofantrine—Myalgia—Methotrexate—lung cancer	0.000177	0.000912	CcSEcCtD
Halofantrine—Vomiting—Paclitaxel—lung cancer	0.000177	0.00091	CcSEcCtD
Halofantrine—Rash—Paclitaxel—lung cancer	0.000175	0.000902	CcSEcCtD
Halofantrine—Dermatitis—Paclitaxel—lung cancer	0.000175	0.000901	CcSEcCtD
Halofantrine—Discomfort—Methotrexate—lung cancer	0.000175	0.000901	CcSEcCtD
Halofantrine—Back pain—Doxorubicin—lung cancer	0.000174	0.000897	CcSEcCtD
Halofantrine—Headache—Paclitaxel—lung cancer	0.000174	0.000896	CcSEcCtD
Halofantrine—Confusional state—Methotrexate—lung cancer	0.000171	0.000881	CcSEcCtD
Halofantrine—Anaphylactic shock—Methotrexate—lung cancer	0.00017	0.000874	CcSEcCtD
Halofantrine—Asthenia—Docetaxel—lung cancer	0.000169	0.00087	CcSEcCtD
Halofantrine—Nausea—Etoposide—lung cancer	0.000168	0.000867	CcSEcCtD
Halofantrine—Ill-defined disorder—Doxorubicin—lung cancer	0.000167	0.00086	CcSEcCtD
Halofantrine—Pruritus—Docetaxel—lung cancer	0.000167	0.000858	CcSEcCtD
Halofantrine—Nausea—Paclitaxel—lung cancer	0.000165	0.00085	CcSEcCtD
Halofantrine—Malaise—Doxorubicin—lung cancer	0.000162	0.000836	CcSEcCtD
Halofantrine—Anorexia—Methotrexate—lung cancer	0.000162	0.000833	CcSEcCtD
Halofantrine—Diarrhoea—Docetaxel—lung cancer	0.000161	0.00083	CcSEcCtD
Halofantrine—Palpitations—Doxorubicin—lung cancer	0.000159	0.000819	CcSEcCtD
Halofantrine—Cough—Doxorubicin—lung cancer	0.000157	0.000809	CcSEcCtD
Halofantrine—Convulsion—Doxorubicin—lung cancer	0.000156	0.000803	CcSEcCtD
Halofantrine—Dizziness—Docetaxel—lung cancer	0.000156	0.000802	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000155	0.000796	CcSEcCtD
Halofantrine—Arthralgia—Doxorubicin—lung cancer	0.000153	0.000789	CcSEcCtD
Halofantrine—Chest pain—Doxorubicin—lung cancer	0.000153	0.000789	CcSEcCtD
Halofantrine—Myalgia—Doxorubicin—lung cancer	0.000153	0.000789	CcSEcCtD
Halofantrine—Paraesthesia—Methotrexate—lung cancer	0.000152	0.000785	CcSEcCtD
Halofantrine—Discomfort—Doxorubicin—lung cancer	0.000151	0.00078	CcSEcCtD
Halofantrine—Vomiting—Docetaxel—lung cancer	0.00015	0.000771	CcSEcCtD
Halofantrine—Dyspepsia—Methotrexate—lung cancer	0.000149	0.000769	CcSEcCtD
Halofantrine—Rash—Docetaxel—lung cancer	0.000148	0.000765	CcSEcCtD
Halofantrine—Dermatitis—Docetaxel—lung cancer	0.000148	0.000764	CcSEcCtD
Halofantrine—Confusional state—Doxorubicin—lung cancer	0.000148	0.000763	CcSEcCtD
Halofantrine—Decreased appetite—Methotrexate—lung cancer	0.000148	0.00076	CcSEcCtD
Halofantrine—Headache—Docetaxel—lung cancer	0.000148	0.00076	CcSEcCtD
Halofantrine—Anaphylactic shock—Doxorubicin—lung cancer	0.000147	0.000757	CcSEcCtD
Halofantrine—Fatigue—Methotrexate—lung cancer	0.000146	0.000753	CcSEcCtD
Halofantrine—Anorexia—Doxorubicin—lung cancer	0.00014	0.000721	CcSEcCtD
Halofantrine—Nausea—Docetaxel—lung cancer	0.00014	0.00072	CcSEcCtD
Halofantrine—Feeling abnormal—Methotrexate—lung cancer	0.00014	0.00072	CcSEcCtD
Halofantrine—Gastrointestinal pain—Methotrexate—lung cancer	0.000139	0.000715	CcSEcCtD
Halofantrine—Urticaria—Methotrexate—lung cancer	0.000135	0.000694	CcSEcCtD
Halofantrine—Abdominal pain—Methotrexate—lung cancer	0.000134	0.000691	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000134	0.000689	CcSEcCtD
Halofantrine—Paraesthesia—Doxorubicin—lung cancer	0.000132	0.00068	CcSEcCtD
Halofantrine—Dyspepsia—Doxorubicin—lung cancer	0.000129	0.000666	CcSEcCtD
Halofantrine—Decreased appetite—Doxorubicin—lung cancer	0.000128	0.000658	CcSEcCtD
Halofantrine—Fatigue—Doxorubicin—lung cancer	0.000127	0.000652	CcSEcCtD
Halofantrine—Constipation—Doxorubicin—lung cancer	0.000126	0.000647	CcSEcCtD
Halofantrine—Asthenia—Methotrexate—lung cancer	0.000122	0.000627	CcSEcCtD
Halofantrine—Feeling abnormal—Doxorubicin—lung cancer	0.000121	0.000624	CcSEcCtD
Halofantrine—Gastrointestinal pain—Doxorubicin—lung cancer	0.00012	0.000619	CcSEcCtD
Halofantrine—Pruritus—Methotrexate—lung cancer	0.00012	0.000618	CcSEcCtD
Halofantrine—Urticaria—Doxorubicin—lung cancer	0.000117	0.000601	CcSEcCtD
Halofantrine—Abdominal pain—Doxorubicin—lung cancer	0.000116	0.000598	CcSEcCtD
Halofantrine—Diarrhoea—Methotrexate—lung cancer	0.000116	0.000598	CcSEcCtD
Halofantrine—Dizziness—Methotrexate—lung cancer	0.000112	0.000578	CcSEcCtD
Halofantrine—Vomiting—Methotrexate—lung cancer	0.000108	0.000556	CcSEcCtD
Halofantrine—Rash—Methotrexate—lung cancer	0.000107	0.000551	CcSEcCtD
Halofantrine—Dermatitis—Methotrexate—lung cancer	0.000107	0.000551	CcSEcCtD
Halofantrine—Headache—Methotrexate—lung cancer	0.000106	0.000547	CcSEcCtD
Halofantrine—Asthenia—Doxorubicin—lung cancer	0.000105	0.000543	CcSEcCtD
Halofantrine—Pruritus—Doxorubicin—lung cancer	0.000104	0.000535	CcSEcCtD
Halofantrine—Nausea—Methotrexate—lung cancer	0.000101	0.000519	CcSEcCtD
Halofantrine—Diarrhoea—Doxorubicin—lung cancer	0.000101	0.000518	CcSEcCtD
Halofantrine—Dizziness—Doxorubicin—lung cancer	9.72e-05	0.0005	CcSEcCtD
Halofantrine—Vomiting—Doxorubicin—lung cancer	9.34e-05	0.000481	CcSEcCtD
Halofantrine—Rash—Doxorubicin—lung cancer	9.27e-05	0.000477	CcSEcCtD
Halofantrine—Dermatitis—Doxorubicin—lung cancer	9.26e-05	0.000477	CcSEcCtD
Halofantrine—Headache—Doxorubicin—lung cancer	9.21e-05	0.000474	CcSEcCtD
Halofantrine—Nausea—Doxorubicin—lung cancer	8.73e-05	0.00045	CcSEcCtD
Halofantrine—CYP2D6—Biological oxidations—GSTM1—lung cancer	5.79e-05	0.000697	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ATP5H—lung cancer	5.77e-05	0.000695	CbGpPWpGaD
Halofantrine—CYP3A5—Biological oxidations—POMC—lung cancer	5.75e-05	0.000693	CbGpPWpGaD
Halofantrine—CYP2D6—Metapathway biotransformation—GSTM1—lung cancer	5.71e-05	0.000687	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—CYP1A1—lung cancer	5.49e-05	0.000661	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	5.48e-05	0.00066	CbGpPWpGaD
Halofantrine—CYP2D6—Metapathway biotransformation—CYP1A1—lung cancer	5.41e-05	0.000652	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	5.31e-05	0.000639	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PLBD1—lung cancer	5.15e-05	0.000619	CbGpPWpGaD
Halofantrine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	5.04e-05	0.000606	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ATP5H—lung cancer	5e-05	0.000602	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—CYP2E1—lung cancer	4.99e-05	0.000601	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—POMC—lung cancer	4.98e-05	0.0006	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	4.93e-05	0.000593	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—COL4A3BP—lung cancer	4.83e-05	0.000581	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—AZIN2—lung cancer	4.83e-05	0.000581	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HSD17B10—lung cancer	4.71e-05	0.000566	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	4.59e-05	0.000553	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PLBD1—lung cancer	4.46e-05	0.000536	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	4.38e-05	0.000528	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CKB—lung cancer	4.37e-05	0.000527	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—GSTP1—lung cancer	4.12e-05	0.000496	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTM2—lung cancer	4.11e-05	0.000495	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CNDP2—lung cancer	4.11e-05	0.000495	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ATP5H—lung cancer	4.1e-05	0.000494	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—POMC—lung cancer	4.09e-05	0.000493	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HSD17B10—lung cancer	4.08e-05	0.000491	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	4.06e-05	0.000489	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—MTMR3—lung cancer	4e-05	0.000482	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—HRAS—lung cancer	3.93e-05	0.000473	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PGAM1—lung cancer	3.9e-05	0.000469	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CKB—lung cancer	3.79e-05	0.000456	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—GSTM1—lung cancer	3.79e-05	0.000456	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	3.73e-05	0.000449	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP2A7—lung cancer	3.72e-05	0.000448	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PLBD1—lung cancer	3.66e-05	0.00044	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—SDC4—lung cancer	3.64e-05	0.000438	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—CYP1A1—lung cancer	3.59e-05	0.000432	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTM2—lung cancer	3.56e-05	0.000429	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CNDP2—lung cancer	3.56e-05	0.000429	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	3.54e-05	0.000426	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—MTMR3—lung cancer	3.47e-05	0.000417	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PGAM1—lung cancer	3.38e-05	0.000407	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HSD17B10—lung cancer	3.35e-05	0.000403	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—RRM1—lung cancer	3.32e-05	0.000399	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTA3—lung cancer	3.32e-05	0.000399	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP2A7—lung cancer	3.22e-05	0.000388	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—COL4A3BP—lung cancer	3.16e-05	0.00038	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—AZIN2—lung cancer	3.16e-05	0.00038	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—SDC4—lung cancer	3.15e-05	0.00038	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—B4GALT5—lung cancer	3.12e-05	0.000375	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CKB—lung cancer	3.11e-05	0.000374	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTA4—lung cancer	3.03e-05	0.000365	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTA2—lung cancer	2.96e-05	0.000356	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTM2—lung cancer	2.92e-05	0.000352	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CNDP2—lung cancer	2.92e-05	0.000352	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—RRM1—lung cancer	2.87e-05	0.000346	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTA3—lung cancer	2.87e-05	0.000346	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTA1—lung cancer	2.85e-05	0.000343	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—MTMR3—lung cancer	2.85e-05	0.000342	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ABCC3—lung cancer	2.82e-05	0.000339	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PGAM1—lung cancer	2.77e-05	0.000334	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—AKR1C1—lung cancer	2.73e-05	0.000329	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—B4GALT5—lung cancer	2.7e-05	0.000325	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ATP5H—lung cancer	2.68e-05	0.000323	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—POMC—lung cancer	2.68e-05	0.000322	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—UGT1A1—lung cancer	2.65e-05	0.000319	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP2A7—lung cancer	2.65e-05	0.000318	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTA4—lung cancer	2.63e-05	0.000316	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SDC4—lung cancer	2.59e-05	0.000312	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.57e-05	0.000309	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTA2—lung cancer	2.56e-05	0.000308	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GNG11—lung cancer	2.56e-05	0.000308	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTA1—lung cancer	2.47e-05	0.000297	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ABCC3—lung cancer	2.44e-05	0.000294	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ALDOA—lung cancer	2.43e-05	0.000293	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PLBD1—lung cancer	2.39e-05	0.000288	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—AKR1C1—lung cancer	2.36e-05	0.000285	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NCOA3—lung cancer	2.36e-05	0.000284	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—RRM1—lung cancer	2.36e-05	0.000284	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTA3—lung cancer	2.36e-05	0.000284	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ADCY1—lung cancer	2.3e-05	0.000277	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ABCG2—lung cancer	2.3e-05	0.000277	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—UGT1A1—lung cancer	2.3e-05	0.000276	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HPGDS—lung cancer	2.25e-05	0.000271	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ENO2—lung cancer	2.25e-05	0.000271	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PPP2R1B—lung cancer	2.24e-05	0.00027	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—B4GALT5—lung cancer	2.22e-05	0.000267	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GNG11—lung cancer	2.21e-05	0.000266	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.2e-05	0.000265	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HSD17B10—lung cancer	2.19e-05	0.000263	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTT1—lung cancer	2.19e-05	0.000263	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GCLC—lung cancer	2.16e-05	0.00026	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP2A6—lung cancer	2.16e-05	0.00026	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTA4—lung cancer	2.16e-05	0.00026	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ALDOA—lung cancer	2.11e-05	0.000254	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTA2—lung cancer	2.1e-05	0.000253	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ENO1—lung cancer	2.05e-05	0.000247	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NCOA3—lung cancer	2.05e-05	0.000246	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CKB—lung cancer	2.03e-05	0.000245	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTA1—lung cancer	2.03e-05	0.000244	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.01e-05	0.000242	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ABCC3—lung cancer	2e-05	0.000241	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ABCG2—lung cancer	1.99e-05	0.00024	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ADCY1—lung cancer	1.99e-05	0.00024	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HPGDS—lung cancer	1.95e-05	0.000235	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ENO2—lung cancer	1.95e-05	0.000235	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—AKR1C1—lung cancer	1.94e-05	0.000234	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PPP2R1B—lung cancer	1.94e-05	0.000233	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.91e-05	0.00023	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CNDP2—lung cancer	1.91e-05	0.00023	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTM2—lung cancer	1.91e-05	0.00023	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTT1—lung cancer	1.89e-05	0.000228	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—UGT1A1—lung cancer	1.88e-05	0.000227	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GCLC—lung cancer	1.87e-05	0.000225	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP2A6—lung cancer	1.87e-05	0.000225	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.86e-05	0.000224	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—MTMR3—lung cancer	1.86e-05	0.000224	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP2E1—lung cancer	1.84e-05	0.000221	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GNG11—lung cancer	1.82e-05	0.000219	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NQO1—lung cancer	1.82e-05	0.000219	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PGAM1—lung cancer	1.81e-05	0.000218	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ENO1—lung cancer	1.77e-05	0.000214	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.77e-05	0.000213	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.74e-05	0.00021	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ALDOA—lung cancer	1.73e-05	0.000208	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP2A7—lung cancer	1.73e-05	0.000208	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SDC4—lung cancer	1.69e-05	0.000204	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NCOA3—lung cancer	1.68e-05	0.000202	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—STK11—lung cancer	1.64e-05	0.000197	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ADCY1—lung cancer	1.63e-05	0.000197	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ABCG2—lung cancer	1.63e-05	0.000197	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ENO2—lung cancer	1.6e-05	0.000193	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HPGDS—lung cancer	1.6e-05	0.000193	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.59e-05	0.000192	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP2E1—lung cancer	1.59e-05	0.000192	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NQO1—lung cancer	1.57e-05	0.000189	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTT1—lung cancer	1.55e-05	0.000187	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—RRM1—lung cancer	1.54e-05	0.000186	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTA3—lung cancer	1.54e-05	0.000186	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.54e-05	0.000185	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GCLC—lung cancer	1.54e-05	0.000185	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP2A6—lung cancer	1.54e-05	0.000185	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.53e-05	0.000184	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTP1—lung cancer	1.52e-05	0.000182	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CAT—lung cancer	1.47e-05	0.000177	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ENO1—lung cancer	1.46e-05	0.000175	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—B4GALT5—lung cancer	1.45e-05	0.000174	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ABCB1—lung cancer	1.43e-05	0.000173	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—STK11—lung cancer	1.42e-05	0.000171	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTA4—lung cancer	1.41e-05	0.00017	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—TYMS—lung cancer	1.41e-05	0.00017	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTM1—lung cancer	1.39e-05	0.000168	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTA2—lung cancer	1.37e-05	0.000165	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.33e-05	0.00016	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTA1—lung cancer	1.33e-05	0.00016	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP1A1—lung cancer	1.32e-05	0.000159	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTP1—lung cancer	1.31e-05	0.000158	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ABCC3—lung cancer	1.31e-05	0.000158	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ERCC2—lung cancer	1.31e-05	0.000158	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP2E1—lung cancer	1.31e-05	0.000157	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NQO1—lung cancer	1.29e-05	0.000155	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CAT—lung cancer	1.28e-05	0.000154	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.27e-05	0.000153	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—AKR1C1—lung cancer	1.27e-05	0.000153	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ABCB1—lung cancer	1.24e-05	0.00015	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—UGT1A1—lung cancer	1.23e-05	0.000148	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—TYMS—lung cancer	1.22e-05	0.000147	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTM1—lung cancer	1.21e-05	0.000145	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GNG11—lung cancer	1.19e-05	0.000143	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—STK11—lung cancer	1.16e-05	0.00014	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP1A1—lung cancer	1.14e-05	0.000138	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ERCC2—lung cancer	1.13e-05	0.000136	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—APOA1—lung cancer	1.13e-05	0.000136	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ALDOA—lung cancer	1.13e-05	0.000136	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NCOA3—lung cancer	1.1e-05	0.000132	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTP1—lung cancer	1.08e-05	0.00013	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ADCY1—lung cancer	1.07e-05	0.000129	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ABCG2—lung cancer	1.07e-05	0.000129	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CAT—lung cancer	1.05e-05	0.000126	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HPGDS—lung cancer	1.05e-05	0.000126	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ENO2—lung cancer	1.05e-05	0.000126	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.04e-05	0.000125	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PIK3CG—lung cancer	1.03e-05	0.000124	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ABCB1—lung cancer	1.02e-05	0.000123	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTT1—lung cancer	1.02e-05	0.000122	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GCLC—lung cancer	1e-05	0.000121	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP2A6—lung cancer	1e-05	0.000121	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—TYMS—lung cancer	1e-05	0.000121	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTM1—lung cancer	9.9e-06	0.000119	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—POMC—lung cancer	9.84e-06	0.000118	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—APOA1—lung cancer	9.81e-06	0.000118	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CREBBP—lung cancer	9.59e-06	0.000115	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ENO1—lung cancer	9.52e-06	0.000115	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	9.39e-06	0.000113	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP1A1—lung cancer	9.39e-06	0.000113	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ERCC2—lung cancer	9.31e-06	0.000112	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PIK3CD—lung cancer	9.09e-06	0.000109	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ALB—lung cancer	8.97e-06	0.000108	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PIK3CG—lung cancer	8.95e-06	0.000108	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP2E1—lung cancer	8.54e-06	0.000103	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—POMC—lung cancer	8.52e-06	0.000103	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NQO1—lung cancer	8.45e-06	0.000102	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CREBBP—lung cancer	8.3e-06	9.99e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—APOA1—lung cancer	8.05e-06	9.69e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PIK3CB—lung cancer	7.92e-06	9.54e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PIK3CD—lung cancer	7.87e-06	9.48e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PTGS2—lung cancer	7.85e-06	9.45e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ALB—lung cancer	7.77e-06	9.35e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—STK11—lung cancer	7.61e-06	9.16e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PIK3CG—lung cancer	7.35e-06	8.85e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTP1—lung cancer	7.04e-06	8.48e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—POMC—lung cancer	7e-06	8.42e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PIK3CB—lung cancer	6.86e-06	8.26e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CAT—lung cancer	6.85e-06	8.25e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PTEN—lung cancer	6.85e-06	8.24e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CREBBP—lung cancer	6.82e-06	8.2e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PTGS2—lung cancer	6.8e-06	8.18e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ABCB1—lung cancer	6.67e-06	8.03e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—TYMS—lung cancer	6.55e-06	7.88e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—EP300—lung cancer	6.53e-06	7.86e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTM1—lung cancer	6.47e-06	7.79e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PIK3CD—lung cancer	6.46e-06	7.78e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ALB—lung cancer	6.38e-06	7.68e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP1A1—lung cancer	6.14e-06	7.39e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ERCC2—lung cancer	6.09e-06	7.33e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PTEN—lung cancer	5.93e-06	7.14e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—EP300—lung cancer	5.65e-06	6.81e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PIK3CB—lung cancer	5.63e-06	6.78e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PTGS2—lung cancer	5.58e-06	6.72e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—APOA1—lung cancer	5.26e-06	6.34e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PTEN—lung cancer	4.87e-06	5.86e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PIK3CA—lung cancer	4.83e-06	5.81e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PIK3CG—lung cancer	4.81e-06	5.79e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—EP300—lung cancer	4.64e-06	5.59e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—POMC—lung cancer	4.58e-06	5.51e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CREBBP—lung cancer	4.46e-06	5.36e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PIK3CD—lung cancer	4.23e-06	5.09e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PIK3CA—lung cancer	4.18e-06	5.03e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ALB—lung cancer	4.17e-06	5.02e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—AKT1—lung cancer	3.95e-06	4.75e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PIK3CB—lung cancer	3.68e-06	4.43e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PTGS2—lung cancer	3.65e-06	4.39e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PIK3CA—lung cancer	3.43e-06	4.13e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—AKT1—lung cancer	3.42e-06	4.11e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PTEN—lung cancer	3.18e-06	3.83e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—EP300—lung cancer	3.04e-06	3.65e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—AKT1—lung cancer	2.81e-06	3.38e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PIK3CA—lung cancer	2.25e-06	2.7e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—AKT1—lung cancer	1.83e-06	2.21e-05	CbGpPWpGaD
